-
1
-
-
0030681408
-
Nitric oxide in single-breath exhalation in humans
-
Suzuki H and Krasney JA: Nitric oxide in single-breath exhalation in humans. Jpn J Physiol 47: 335-339, 1997
-
(1997)
Jpn J Physiol
, vol.47
, pp. 335-339
-
-
Suzuki, H.1
Krasney, J.A.2
-
2
-
-
0027331601
-
Endogenous nitric oxide in single exhalations and the change during exercise
-
Persson MG, Wiklund NP, and Gustafsson LE: Endogenous nitric oxide in single exhalations and the change during exercise. Am Rev Respir Dis 148: 1210-1214, 1993
-
(1993)
Am Rev Respir Dis
, vol.148
, pp. 1210-1214
-
-
Persson, M.G.1
Wiklund, N.P.2
Gustafsson, L.E.3
-
3
-
-
0031034566
-
Marked flow-dependence of exhaled nitric oxide using a new technique to exclude nasal nitric oxide
-
Silkoff PE, McClean PA, Slutsky AS, Furlott HG, Hoffstein E, Wakita S, Chapman KR, Szalai JP, and Zamel N: Marked flow-dependence of exhaled nitric oxide using a new technique to exclude nasal nitric oxide. Am J Respir Crit Care Med 155: 260-267, 1997
-
(1997)
Am J Respir Crit Care Med
, vol.155
, pp. 260-267
-
-
Silkoff, P.E.1
McClean, P.A.2
Slutsky, A.S.3
Furlott, H.G.4
Hoffstein, E.5
Wakita, S.6
Chapman, K.R.7
Szalai, J.P.8
Zamel, N.9
-
4
-
-
0029145012
-
Acute and chronic effects of cigarette smoking on exhaled nitric oxide
-
Kharitonov SA, Robbins RA, Yates D, Keatings V, and Barnes PJ: Acute and chronic effects of cigarette smoking on exhaled nitric oxide. Am J Respir Crit Care Med 152: 609-612, 1995
-
(1995)
Am J Respir Crit Care Med
, vol.152
, pp. 609-612
-
-
Kharitonov, S.A.1
Robbins, R.A.2
Yates, D.3
Keatings, V.4
Barnes, P.J.5
-
5
-
-
0027958136
-
Single-breath nitric oxide measurements in asthmatic patients and smokers
-
Persson MG, Zetterström O, Argenius V, Ihre E, and Gustaffsson LE: Single-breath nitric oxide measurements in asthmatic patients and smokers. Lancet 43: 146-147, 1994
-
(1994)
Lancet
, vol.43
, pp. 146-147
-
-
Persson, M.G.1
Zetterström, O.2
Argenius, V.3
Ihre, E.4
Gustaffsson, L.E.5
-
6
-
-
0028053173
-
Increased nitric oxide in exhaled air of asthmatic patients
-
Kharitonov SA, Yates DH, Robbins RA, Logan-Sinclair R, Shinebourne E, and Barnes PJ: Increased nitric oxide in exhaled air of asthmatic patients. Lancet 343: 133-135, 1994
-
(1994)
Lancet
, vol.343
, pp. 133-135
-
-
Kharitonov, S.A.1
Yates, D.H.2
Robbins, R.A.3
Logan-Sinclair, R.4
Shinebourne, E.5
Barnes, P.J.6
-
7
-
-
0029128558
-
Expired nitric oxide levels during treatment of acute asthma
-
Massaro AF, Gaston B, Kita D, Fanta C, Stamler JS, and Drazen JM: Expired nitric oxide levels during treatment of acute asthma. Am J Respir Crit Care Med 152: 800-803, 1995
-
(1995)
Am J Respir Crit Care Med
, vol.152
, pp. 800-803
-
-
Massaro, A.F.1
Gaston, B.2
Kita, D.3
Fanta, C.4
Stamler, J.S.5
Drazen, J.M.6
-
8
-
-
0030022873
-
Inhaled glucocorticoids decrease nitric oxide in exhaled air of asthmatic patients
-
Kharitonov SA, Yates DH, and Barnes PJ: Inhaled glucocorticoids decrease nitric oxide in exhaled air of asthmatic patients. Am J Respir Grit Care Med 153: 454-457, 1996
-
(1996)
Am J Respir Grit Care Med
, vol.153
, pp. 454-457
-
-
Kharitonov, S.A.1
Yates, D.H.2
Barnes, P.J.3
-
9
-
-
0028022515
-
Expression of inducible nitric oxide synthase in human bronchial epithelial cells
-
Robbins RA, Barnes PJ, Springall DR, Warren JW, Kwon OJ, Buttery LDK, Willson AJ, Geller DA, and Polak JM: Expression of inducible nitric oxide synthase in human bronchial epithelial cells. Biochem Biophys Res Commun 203: 209-218, 1994
-
(1994)
Biochem Biophys Res Commun
, vol.203
, pp. 209-218
-
-
Robbins, R.A.1
Barnes, P.J.2
Springall, D.R.3
Warren, J.W.4
Kwon, O.J.5
Buttery, L.D.K.6
Willson, A.J.7
Geller, D.A.8
Polak, J.M.9
-
10
-
-
0029123159
-
Effect of 5-lipoxygenase inhibition on bronchoconstriction and airway inflammation in nocturnal asthma
-
Wenzel SE, Trudeau JB, Kaminsky DA, Cohn J, Martin RJ, and Westcott JY: Effect of 5-lipoxygenase inhibition on bronchoconstriction and airway inflammation in nocturnal asthma. Am J Respir Crit Care Med 152: 897-905, 1995
-
(1995)
Am J Respir Crit Care Med
, vol.152
, pp. 897-905
-
-
Wenzel, S.E.1
Trudeau, J.B.2
Kaminsky, D.A.3
Cohn, J.4
Martin, R.J.5
Westcott, J.Y.6
-
11
-
-
0031800910
-
Effect of zafirlukast (Accolate) on cellular mediators of inflammation
-
Calhoun WJ, Lavins BJ, Minkwitz MC, Evans R, and Gleich GJ, Cohn J: Effect of zafirlukast (Accolate) on cellular mediators of inflammation. Am J Respir Crit Care Med 157: 1381-1389, 1998
-
(1998)
Am J Respir Crit Care Med
, vol.157
, pp. 1381-1389
-
-
Calhoun, W.J.1
Lavins, B.J.2
Minkwitz, M.C.3
Evans, R.4
Gleich, G.J.5
Cohn, J.6
-
12
-
-
0032427719
-
Should antileukotriene therapies be used instead of inhaled corticosteroids in asthma? Yes
-
Drazen JM and Israel E: Should antileukotriene therapies be used instead of inhaled corticosteroids in asthma? Yes. Am J Respir Crit Care Med 158; 1697-1698, 1998
-
(1998)
Am J Respir Crit Care Med
, vol.158
, pp. 1697-1698
-
-
Drazen, J.M.1
Israel, E.2
-
13
-
-
0030903255
-
Leukotriene antagonist prevents exacerbation of asthma during reduction of high-dose inhaled corticosteroid
-
Tamaoki J, Kondo M, Sakai N, Nakata J, Takemura H, Nagai A, Takizawa T, and Konno K: Leukotriene antagonist prevents exacerbation of asthma during reduction of high-dose inhaled corticosteroid. Am J Respir Crit Care Med 155: 1235-1240, 1997
-
(1997)
Am J Respir Crit Care Med
, vol.155
, pp. 1235-1240
-
-
Tamaoki, J.1
Kondo, M.2
Sakai, N.3
Nakata, J.4
Takemura, H.5
Nagai, A.6
Takizawa, T.7
Konno, K.8
-
14
-
-
0032427719
-
Should antileukotriene therapies be used instead of inhaled corticosteroids in asthma? No
-
Wenzel SE: Should antileukotriene therapies be used instead of inhaled corticosteroids in asthma? No. Am J Respir Crit Care Med 158: 1699-1701, 1998
-
(1998)
Am J Respir Crit Care Med
, vol.158
, pp. 1699-1701
-
-
Wenzel, S.E.1
-
16
-
-
0027340363
-
Leukotriene E4 and granulocytic infiltration into asthmatic airways
-
Laitinen LA, Laitinen A, Haahtela T, Vikka V, Spur BW, and Lee TH: Leukotriene E4 and granulocytic infiltration into asthmatic airways. Lancet 341: 989-990, 1993
-
(1993)
Lancet
, vol.341
, pp. 989-990
-
-
Laitinen, L.A.1
Laitinen, A.2
Haahtela, T.3
Vikka, V.4
Spur, B.W.5
Lee, T.H.6
-
17
-
-
0031754251
-
Pranlukast, a cysteinyl leukotriene receptor antagonist, attenuates allergen-induced early- and late-phase bronchoconstriction and airway hyperresponsiveness in asthmatic subjects
-
Hamilton A, Faiferman I, Stober P, Watson RM, and O'Byrne PM: Pranlukast, a cysteinyl leukotriene receptor antagonist, attenuates allergen-induced early- and late-phase bronchoconstriction and airway hyperresponsiveness in asthmatic subjects. J Allergy Clin Immunol 102: 170-172, 1998
-
(1998)
J Allergy Clin Immunol
, vol.102
, pp. 170-172
-
-
Hamilton, A.1
Faiferman, I.2
Stober, P.3
Watson, R.M.4
O'Byrne, P.M.5
-
18
-
-
0029050604
-
Allergen-induced late asthmatic reactions are associated with elevation of exhaled nitric oxide
-
Kharitonov SA, O'Connor BJ, Evans DJ, and Barnes PJ: Allergen-induced late asthmatic reactions are associated with elevation of exhaled nitric oxide. Am J Respir Crit Care Med 151:1894-1899, 1995
-
(1995)
Am J Respir Crit Care Med
, vol.151
, pp. 1894-1899
-
-
Kharitonov, S.A.1
O'Connor, B.J.2
Evans, D.J.3
Barnes, P.J.4
|